Oculis Holding AG OCS
NASDAQ OCS
$12.17 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

Oculis Holding AG (OCS) Operating Expenses (2022 - 2026)

Oculis Holding AG (OCS) posted quarterly Operating Expenses of -$28.0 million for Q1 2026, down 24.32% year-over-year from -$37.0 million in Q1 2025, and down 6.4% quarter-over-quarter from -$26.3 million in Q4 2025.

Analysis

Oculis Holding AG (OCS) Operating Expenses (2022 - 2026) Analysis & Trends

Oculis Holding AG's Operating Expenses history runs 5 years deep, the most recent figure standing at -$28.0 million for Q1 2026.

  • In Q1 2026, Operating Expenses fell 24.32% year-over-year to -$28.0 million; the TTM figure through Mar 2026 stood at -$25.8 billion (down 21.24% YoY), while the FY2025 annual figure was -$100.0 million, down 19.0% from the prior year.
  • Operating Expenses for Q1 2026 stood at -$28.0 million, down from -$26.3 million in the prior quarter.
  • The five-year high for Operating Expenses was -$7.3 million in Q3 2022, with the low at -$25.7 billion in Q3 2025.
  • The 5-year median for Operating Expenses is -$21.1 million (2024), against an average of -$2.9 billion.
  • Peak annual rise in Operating Expenses reached 63.43% in 2024, while the deepest fall reached 141836.6% in 2024.
  • Oculis Holding AG's Operating Expenses stood at -$11.8 million in 2022, then decreased by 18.6% to -$13.9 million in 2023, then slumped by 41.32% to -$19.7 million in 2024, then tumbled by 33.61% to -$26.3 million in 2025, then fell by 6.4% to -$28.0 million in 2026.
  • Business Quant data shows OCS's Operating Expenses at -$28.0 million in Q1 2026, -$26.3 million in Q4 2025, and -$25.7 billion in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 2.09 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 3.00 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -1.05 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 960.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 505.13 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.21 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 1.06 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 541.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 427.03 Mn
10 Oculis Holding AG 634.75 Mn 345.87 Mn - -30.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -30.21 Mn
Mar 31, 2026 -28.01 Mn
Dec 31, 2025 -26.33 Mn
Sep 30, 2025 -25.68 Mn
Jun 30, 2025 -25.40 Mn
Mar 31, 2025 -22.53 Mn
Dec 31, 2024 -19.71 Mn
Sep 30, 2024 -21.18 Mn
Jun 30, 2024 -25.13 Mn
Mar 31, 2024 -17.82 Mn
Dec 31, 2023 -13.94 Mn
Sep 30, 2023 -14.92 Mn
Jun 30, 2023 -12.23 Mn
Mar 31, 2023 -48.71 Mn
Dec 31, 2022 -11.76 Mn
Sep 30, 2022 -7.33 Mn
Jun 30, 2022 -9.84 Mn